Linked Data API

Show Search Form

Search Results

1127173
registered interest false remove filter
date remove filter
answering body
Department for International Development remove filter
answering dept id 20 more like this
answering dept short name International Development more like this
answering dept sort name International Development more like this
hansard heading Development Aid: Climate Change more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for International Development, pursuant to the Answer of 16 April 2019 to Question HL15044 on Developing Countries: Climate Change, how much of the £5.8 billion allocated to international climate finance between 2016-17 and 2020-21 will be spent on tackling loss and damage in climate-vulnerable countries. more like this
tabling member constituency Liverpool, Walton more like this
tabling member printed
Dan Carden more like this
uin 255379 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-05-21more like thismore than 2019-05-21
answer text <p>Action to avert, minimize and address loss and damage associated with climate change is intricately bound up with action on mitigation, adaptation, disaster risk reduction and disaster preparedness and response. We therefore do not see that attempting to define a separate category of finance for loss and damage as useful or practical. Of the £5.8bn on climate finance we have committed to spend from 2016-2021 the UK aims to spend 50% on adaptation and 50% on mitigation.</p> more like this
answering member constituency Penrith and The Border more like this
answering member printed Rory Stewart more like this
question first answered
less than 2019-05-21T16:48:42.047Zmore like thisremove minimum value filter
answering member
4137
label Biography information for Rory Stewart more like this
tabling member
4651
label Biography information for Dan Carden more like this
1127248
registered interest false remove filter
date remove filter
answering body
Department for International Development remove filter
answering dept id 20 more like this
answering dept short name International Development more like this
answering dept sort name International Development more like this
hansard heading UNRWA: Finance more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government what action they are taking to ensure that aid programmes of the UN Relief and Works Agency for Palestine Refugees in the Near East and the UN system in general have long-term sustainability. more like this
tabling member printed
Lord Judd more like this
uin HL15801 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-05-30more like thismore than 2019-05-30
answer text <p>The UK supports a two-state solution to the Israel-Palestine conflict and the UK Government believe that the only way to achieve a lasting solution for refugees is a negotiated solution to the conflict.</p><p> </p><p>In the interim, the UK is a leading donor to UNRWA and will provide up to £80m over the next two years. This will help to provide essential services, including healthcare and education, for millions of Palestinian refugees living in Jordan, Syria, Lebanon, Gaza and the West Bank.</p><p> </p><p>The Government has also acted to ensure the long-term sustainability of the UN system in general by supporting the Secretary General’s reform agenda, including the Funding Compact which is being discussed at ECOSOC in New York in late May.</p><p> </p><p>The UK is committed to getting the best value for the UK taxpayers’ money in our aid programmes. We work closely with our UN partners to ensure programmes deliver the best development outcomes and value for money.</p> more like this
answering member printed Baroness Sugg more like this
question first answered
less than 2019-05-30T12:52:46.573Zmore like thismore than 2019-05-30T12:52:46.573Z
answering member
4584
label Biography information for Baroness Sugg more like this
tabling member
1660
label Biography information for Lord Judd more like this
1127261
registered interest false remove filter
date remove filter
answering body
Department for International Development remove filter
answering dept id 20 more like this
answering dept short name International Development more like this
answering dept sort name International Development more like this
hansard heading Pneumococcal Diseases: Vaccination more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government what plans they have to extend their engagement with the Advanced Market Commitment beyond the pilot for pneumococcal vaccine, run via Gavi, the Vaccine Alliance. more like this
tabling member printed
Lord Stevenson of Balmacara more like this
uin HL15814 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-05-30more like thismore than 2019-05-30
answer text <p>The Advance Market Commitment (AMC) for Pneumococcal Vaccines is a dynamic financing instrument of Gavi, the Vaccine Alliance. Its objective is to reduce deaths from severe pneumonia by reducing the cost of the pneumococcal vaccine. The AMC does this by incentivising vaccine manufacturers and generating greater competition by encouraging additional manufacturers to the market. So far, 114 million children have been vaccinated with AMC-supported pneumococcal vaccines, saving 762,000 lives.</p><p> </p><p>DFID has committed $485 million to AMC from 2010 until 2020. The AMC has consistently delivered and performs very strongly. It scored an A+ in its last Annual Review. The current end date is scheduled for December 2020. DFID are currently reviewing vaccine demand projections and in discussions with other stakeholders whether an extension is required in order to attract new manufacturers and generate wider benefits. This review is in line with our approach to maximise effectiveness and ensure good value for money.</p>
answering member printed Baroness Sugg more like this
question first answered
less than 2019-05-30T12:54:28.227Zmore like thismore than 2019-05-30T12:54:28.227Z
answering member
4584
label Biography information for Baroness Sugg more like this
tabling member
4175
label Biography information for Lord Stevenson of Balmacara more like this
1127262
registered interest false remove filter
date remove filter
answering body
Department for International Development remove filter
answering dept id 20 more like this
answering dept short name International Development more like this
answering dept sort name International Development more like this
hansard heading Pneumococcal Diseases: Vaccination more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government what financial commitment they intend to make to the Advanced Market Commitment pilot for pneumococcal vaccine beyond 2020; and what estimate they have made of the expected total funding. more like this
tabling member printed
Lord Stevenson of Balmacara more like this
uin HL15815 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-05-30more like thismore than 2019-05-30
answer text <p>The Advance Market Commitment (AMC) for Pneumococcal Vaccines is a dynamic financing instrument of Gavi, the Vaccine Alliance. Its objective is to reduce deaths from severe pneumonia by reducing the cost of the pneumococcal vaccine. The AMC does this by incentivising vaccine manufacturers and generating greater competition by encouraging additional manufacturers to the market. So far, 114 million children have been vaccinated with AMC-supported pneumococcal vaccines, saving 762,000 lives.</p><p> </p><p>The expected total funding for DFID’s contribution to AMC is $485 million from 2010 until the programme completes in 2020. To date, the UK have made no new financial commitments for AMC beyond completion of the programme in 2020. As part of the planning process for the next phase for Gavi, the UK and other stakeholders are exploring all innovative financing options which can improve global immunisation in poor countries.</p> more like this
answering member printed Baroness Sugg more like this
question first answered
less than 2019-05-30T12:54:48.77Zmore like thismore than 2019-05-30T12:54:48.77Z
answering member
4584
label Biography information for Baroness Sugg more like this
tabling member
4175
label Biography information for Lord Stevenson of Balmacara more like this
1127263
registered interest false remove filter
date remove filter
answering body
Department for International Development remove filter
answering dept id 20 more like this
answering dept short name International Development more like this
answering dept sort name International Development more like this
hansard heading Pneumococcal Diseases: Vaccination more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government what assessment they have made of the effectiveness of the Advanced Market Commitment for pneumococcal vaccines; and whether it should be continued. more like this
tabling member printed
Lord Stevenson of Balmacara more like this
uin HL15816 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-05-30more like thismore than 2019-05-30
answer text <p>The Advance Market Commitment (AMC) for Pneumococcal Vaccines (PCV) incentivises vaccine manufacturers and generates competition by encouraging additional manufacturers to the market. So far, 114 million children have been vaccinated with AMC-supported pneumococcal vaccines, saving 762,000 lives.</p><p> </p><p>The UK assess AMC to be an effective and efficient mechanism to improve vaccine coverage at a lower cost. It scored an A+ in its last annual review. In March 2019, Pfizer reduced the price of PCV for 73 developing countries from US$3.30 in 2017 to US$2.90 per dose. This further reduction is estimated to save Gavi and developing country governments up to US$ 4.1 million.</p><p> </p><p>An independent 2015 evaluation identified AMC’s supply arrangements as a critical factor in encouraging vaccine manufacturers to expand their capacity to produce safe, effective vaccines. As part of the planning process for the next phase for Gavi, the UK and other stakeholders are exploring all innovative financing options which can improve global immunisation in poor countries.</p>
answering member printed Baroness Sugg more like this
question first answered
less than 2019-05-30T12:55:11.227Zmore like thismore than 2019-05-30T12:55:11.227Z
answering member
4584
label Biography information for Baroness Sugg more like this
tabling member
4175
label Biography information for Lord Stevenson of Balmacara more like this
1127264
registered interest false remove filter
date remove filter
answering body
Department for International Development remove filter
answering dept id 20 more like this
answering dept short name International Development more like this
answering dept sort name International Development more like this
hansard heading International Finance Facility for Immunisation more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government whether they will commit to supporting the International Finance Facility for Immunisation in the next funding period. more like this
tabling member printed
Lord Stevenson of Balmacara more like this
uin HL15817 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-05-30more like thismore than 2019-05-30
answer text <p>The International Financing Facility for Immunisation (IFFIm) was launched in 2006. IFFIm’s frontloading capability for vaccine funding has allowed more than 80 million children to be immunised ahead of time, without having to wait until Gavi has received pledged donor grants.</p><p> </p><p>Subject to continued strong performance, the UK will fund IFFIm until 2029. More broadly, the UK recognises the important role of innovative financing mechanisms for vaccine delivery. In our role as hosts of the 2020 Gavi Replenishment, we will encourage discussions with other donors and other stakeholders on ways to expand innovative financing to vaccinate children in poor countries.</p> more like this
answering member printed Baroness Sugg more like this
question first answered
less than 2019-05-30T13:03:56.897Zmore like thismore than 2019-05-30T13:03:56.897Z
answering member
4584
label Biography information for Baroness Sugg more like this
tabling member
4175
label Biography information for Lord Stevenson of Balmacara more like this